Frontier Path VC
Venture capitalLondon · Growth–Late Stage · 1 people tracked
Find your way into Frontier Path VC
157 people in our graph share verified history with the Frontier Path VC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Frontier Path targets post-revenue technology companies with validated market and product fit across smart healthcare (medical devices, digital health, wellness), smart mobility (electric vehicles, autonomous transport), and smart environment sectors (cybersecurity, agriculture, fintech, logistics). The firm emphasizes companies with strong technology foundations and business models, seeking both secondary and primary investment opportunities globally with a concentration in North American markets.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from public directories
What they invest in
from 6 of 7 portfolio companiesHealthtech ×5Biotech ×4Medical Devices ×3Deep Tech ×2AI & Machine Learning ×1Cleantech ×1Climate Tech ×1Cybersecurity ×1
HQs:United States×5
Investments · 7 tracked
founders shown can be your intro pathCo-investorsFalconX Ventures
Breaking develops engineered microorganisms and enzymes—notably a microbe variant called MICROBE X-32—that biologically degrade many types of plastic waste into organic matter.
BiotechCleantechClimate Tech
Sukanya Punthambaker(Founder)Vaskar Gnyawali(Founder)inGeorge Church(Founder)Donald Ingber(Co-founder)Alba Tull(Founder)inKent Wakeford(Founder)
Co-investorsCarnrite Ventures
Cylera provides a healthcare cybersecurity platform focused on connected medical devices, IoT, and IT assets, giving hospitals and health systems visibility, risk assessment, and threat detection across their environments.
CybersecurityHealthtechIoTNew York, US
Timur Ozekcin(Executive Officer, Director)inSean Abraham(Executive Officer, Director)inApostolos Bakoyiannis(Executive Officer)Owen Wilson(Director)
Co-investorsContour Venture PartnersDreamit VenturesEpsilon Health InvestorsGreat Oaks Venture CapitalRho Capital PartnersRho Ventures+1 more
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)in
Co-investorsAera VCFrontera Technology VenturesJames Beshara FundJLSMagnetic VenturesNoetic+9 more
neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility.
Deep TechHealthtechMedical DevicesSan Francisco, US
Amit Vohra(Executive Officer, Director)inAbhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)
BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)
Co-investorsShangBay Capital LLC
Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.
BiotechDeep TechHealthtechMedical DevicesAustin, US
Matt Angle(Founder and CEO)in
Co-investors15th RockAlpha EdisonAnthropy PartnersCapital FactoryCoastCapFusion+14 more
Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions.
BiotechHardwareHealthtechMedical DevicesOakland, US
Amit Vohra(Executive Officer, Director)inMichael Bartholomew(Executive Officer, Director)inDinesh Kumar(Executive Officer)in
BoardJonathan Chen(Director)Derek Hennecke(Director)inDushyant Chipalkatty(Director)
Co-investorsAngel Physicians FundBand of AngelsZynext Ventures
Portfolio news
latest coverage across their companies
Gilgamesh Pharmaceuticals · wmbdradio.com · Jul 16, 2026
Frequently asked questions
- How many investments has Frontier Path VC made?
- Frontier Path VC has 7 tracked investments.
- What stage does Frontier Path VC invest at?
- Frontier Path VC invests at the Growth, Late Stage stages.
- What sectors does Frontier Path VC focus on?
- Frontier Path VC focuses on AgTech, AI & Machine Learning, Circular Economy, Cybersecurity, Data & Infrastructure, Deep Tech, Digital Health, E-commerce, EdTech, Fintech, FoodTech, Healthtech, Logistics & Supply Chain, Medical Devices, Mobility & Transportation, PropTech, Wellness & Fitness.
- Where is Frontier Path VC located?
- Frontier Path VC is headquartered in London, GB.
- Who does Frontier Path VC co-invest with?
- Frontier Path VC most often shares deals with Prime Movers Lab, Capital Factory, Great Oaks Venture Capital, among 36 tracked co-investors.
Co-investors · 1
Flyer One Ventures is an early-stage venture capital fund led and backed by entrepreneurs who built one of the largest tech companies in Central and Eastern Europe. It partners with CEE and Ukrainian founders building the application layer of global software.
Firms observed investing alongside Frontier Path VC, from public investor directories. Shared companies are the overlap with Frontier Path VC's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.
LVX Ventures (LetsVenture) operates an AI-native private-market investing platform connecting investors and family offices with early-stage startups, and manages an angel fund.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Cerity Partners Ventures provides Venture Capital as a Service (VCaaS) for corporations, helping them launch and manage venture capital programs and invest in and partner with startups.